Trial intelligence / Profile preview

Remimazolam vs propofol sedation for colonoscopic polypectomy

ChiCTR2100046928Phase 4Not yet recruiting

Sponsor
Liaocheng City People's Hospital
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in colonic polyp comparing Propofol group with Remimazolam group (2 arms). Primary endpoints: Recovery time and Sedation success rate. Planned start Jun 2021; status: not yet recruiting.

02

Drugs

remimazolampropofol
03

Conditions

colonic polyp

Beyond the preview

Go deeper on ChiCTR2100046928.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100046928.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call